ReviewHepatic oncology2014

Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial.

Lorenza Rimassa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.